Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: Still a valid treatment in appropriately selected patients

Europace

Volumn 10, Issue 4, 2008, Pages 425-432

  Betts, Timothy R ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Ablation; Atrial fibrillation; Atrioventricular node; Heart block; Pacemaker

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CLINICAL TRIAL; DEFIBRILLATOR; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY VEIN; QUALITY OF LIFE; REVIEW; SUDDEN DEATH; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HUMANS; PACEMAKER, ARTIFICIAL; TREATMENT OUTCOME;

EID: 44449156795     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun063     Document Type: Review

References (74)

1. Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982;306:194-200.
2. Kalbfleisch SJ, Williamson B, Man KC, Vorperian V, Hummel JD, Calkins H et al. A randomized comparison of the right- and left-sided approaches to ablation of the atrioventricular junction. Am J Cardiol 1993;72:1406-10.
3. Brignole M, Gammage M, Jordaens L, Sutton R. Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation. Barcelona Discussion Group. Working Group on Arrhythmias of the European Society of Cardiology. Europace 1999;1:8-13.
4. Zivin A, Knight BP, Souza J, Bahu M, Weiss R, Goyal R et al. Predictors of crossover to a left ventricular approach for atrioventricular junction ablation. Am J Cardiol 1997;80:1611-2.
5. Issa ZF. An approach to ablate and pace: AV junction ablation and pacemaker implantation performed concurrently from the same venous access site. Pacing Clin Electrophysiol 2007;30:1116-20.
6. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997;96:2617-24.
7. Olgin JE, Scheinman MM. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol 1993;21:557-64.
8. Ito S, Tada H, Naito S, Kutsumi Y, Miyamori I, Nogami A et al. Randomized comparison of bipolar vs. unipolar plus bipolar recordings during atrioventricular junction ablation: importance and efficacy of unipolar recording. Circ J 2007;71:874-9.
9. Cuello C, Huang SK, Wagshal AB, Pires LA, Mittleman RS, Bonavita GJ. Radiofrequency catheter ablation of the atrioventricular junction by a supravalvular noncoronary aortic cusp approach. Pacing Clin Electrophysiol 1994;17:1182-5.
10. Strickberger SA, Foster PR, Wang PJ, Okishige K, Friedman PL. Intracoronary infusion of dilute ethanol for control of ventricular rate in patients with atrial fibrillation. Pacing Clin Electrophysiol 1993;16:1984-93.
11. Proclemer A, Facchin D, Pagnutti C, Fioretti P, De Michele C. Safety of pacemaker implantation prior to radiofrequency ablation of atrioventricular junction in a single session procedure. Pacing Clin Electrophysiol 2000;23:998-1002.
12. Padeletti L, Michelucci A, Pieragnoli P, Colella A, Musilli N. Atrial septal pacing: a new approach to prevent atrial fibrillation. Pacing Clin Electrophysiol 2004;27:850-4.
13. Ramdat MA, Beukema WP, Oude Luttikhuis HA. Multisite or alternate site pacing for the prevention of atrial fibrillation. Am J Cardiol 1999;83:237D-240D.
14. Marshall HJ, Harris ZI, Griffith MJ, Holder RL, Gammage MD. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. Circulation 1999;99:1587-92.
15. Kamalvand K, Tan K, Kotsakis A, Bucknall C, Sulke N. Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias. J Am Coll Cardiol 1997;30:496-504.
16. Marshall HJ, Harris ZI, Griffith MJ, Gammage MD. Prospective, randomized study of atrioventricular node ablation and mode-switching, dual chamber pacemaker implantation using two different algorithms in patients with paroxysmal atrial fibrillation. Europace 1999;1:20-1.
17. Buys EM, van Hemel NM, Jessurun ER, Kelder JC, Bakema L, Kingma JH. VDDR pacing after His-bundle ablation for paroxysmal atrial fibrillation: a pilot study. Pacing Clin Electrophysiol 1998;21:1869-72.
18. McComb JM, Gribbin GM. Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: determinants and treatment. Europace 1999;1:30-4.
19. Mitchell MA, Ackerman SJ, Nath S, Haines DE, DiMarco JP. Atrial rhythm after atrioventricular junctional ablation. Am J Cardiol 1996;78:1251-4.
20. Queiroga A, Marshall HJ, Clune M, Gammage MD. Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillation. Heart 2003;89:1035-8.
21. Gianfranchi L, Brignole M, Menozzi C, Lolli G, Bottoni N. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol 1998;81:351-4.
22. Wood MA, Curtis AB, Takle-Newhouse TA, Ellenbogen KA. Survival of DDD pacing mode after atrioventricular junction ablation and pacing for refractory atrial fibrillation. Am Heart J 1999;137:682-5.
23. Gillis AM. Selection of pacing mode after interruption of atrioventricular conduction for atrial fibrillation: observations from the PA3 clinical trial. Card Electrophysiol Rev 2003;7:312-4.
24. Gillis AM, Connolly SJ, Lacombe P, Philippon F, Dubuc M, Kerr CR et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation 2000;102:736-41.
25. Hemels ME, Wiesfeld AC, Inberg B, van Dessel PF, Nieuwland W, Tan ES et al. Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation. Europace 2006;8:107-12.
26. Lewalter T, Yang A, Pfeiffer D, Ruiter J, Schnitzler G, Markert T et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin Electrophysiol 2006;29:124-34.
27. Redfearn DP, Yee R. Pacing delivered rate and rhythm control for atrial fibrillation. Curr Opin Cardiol 2006;21:83-7.
28. Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R et al. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002;23:892-900.
29. Gribbin GM, Bourke JP, McComb JM. Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias. Heart 1998;79:548-53.
30. Gasparini M, Mantica M, Brignole M, Gianfranchi L, Menozzi C, Pizzetti F et al. Thromboembolism after atrioventricular node ablation and pacing: long term follow up. Heart 1999;82:494-8.
31. Kay GN, Bubien RS, Epstein AE, Plumb VJ. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol 1988;62:741-4.
32. Rodriguez LM, Smeets JL, Xie B, De Chillou C, Cheriex E, Pieters F et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993;72:1137-41.
33. Twidale N, Sutton K, Bartlett L, Dooley A, Winstanley S, Heddle W et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol 1993;16:1275-84.
34. Brignole M, Gianfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994;74:242-6.
35. Jensen SM, Bergfeldt L, Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1995;18:1609-14.
36. Fitzpatrick AP, Kourouyan HD, Siu A, Lee RJ, Lesh MD, Epstein LM et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996;131:499-507.
37. Buys EM, van Hemel NM, Kelder JC, Ascoop CA, van Dessel PF, Bakema L et al. Exercise capacity after His bundle ablation and rate response ventricular pacing for drug refractory chronic atrial fibrillation. Heart 1997;77:238-41.
38. Kim SG, Sompalli V, Rameneni A, Gadde MK, Pamidi M, Pathapati R et al. Symptomatic improvement after AV nodal ablation and pacemaker implantation for refractory atrial fibrillation and atrial flutter. Angiology 1997;48:933-8.
39. Manolis AG, Katsivas AG, Lazaris EE, Vassilopoulos CV, Louvros NE. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Interv Card Electrophysiol 1998;2:71-6.
40. Marshall HJ, Harris ZI, Griffith MJ, Gammage MD. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation. Heart 1998;79:543-7.
41. Twidale N, Manda V, Nave K, Seal A. Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure. Am Heart J 1998;136:647-57.
42. Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998;98:953-60.
43. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG et al. Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation. Europace 1999;1:15-9.
44. Vanderheyden M, Goethals M, Anguera I, Nellens P, Andries E, Brugada J et al. Hemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system. Pacing Clin Electrophysiol 1997;20:2422-8.
45. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000;101:1138-44.
46. Natale A, Zimerman L, Tomassoni G, Newby K, Leonelli F, Fanelli R et al. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance. Pacing Clin Electrophysiol 1999;22:1634-9.
47. Natale A, Zimerman L, Tomassoni G, Kearney M, Kent V, Brandon MJ et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1996;78:1431-3.
48. Ueng KC, Tsai TP, Tsai CF, Wu DJ, Lin CS, Lee SH et al. Acute and longterm effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response. J Cardiovasc Electrophysiol 2001;12:303-9.
49. Geelen P, Brugada J, Andries E, Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1997;20:343-8.
50. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol 1998;21:641-51.
51. Yeung-Lai-Wah JA, Qi A, Uzun O, Humphries K, Kerr CR. Long-term survival following radiofrequency catheter ablation of atrioventricular junction for atrial fibrillation: clinical and ablation determinants of mortality. J Interv Card Electrophysiol 2002;6:17-23.
52. Ozcan C, Jahangir A, Friedman PA, Hayes DL, Munger TM, Rea RF et al. Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 2002;40:105-10.
53. Peters RH, Wever EF, Hauer RN, Wittkampf FH, Robles de Medina EO. Bradycardia dependent QT prolongation and ventricular fibrillation following catheter ablation of the atrioventricular junction with radiofrequency energy. Pacing Clin Electrophysiol 1994;17:108-12.
54. Nowinski K, Gadler F, Jensen-Urstad M, Bergfeldt L. Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management. Am J Med 2002;113:596-602.
55. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001;344:1043-51.
56. Gasparini M, Mantica M, Brignole M, Coltorti F, Galimberti P, Gianfranchi L et al. Long-term follow-up after atrioventricular nodal ablation and pacing: low incidence of sudden cardiac death. Pacing Clin Electrophysiol 2000;23:1925-9.
57. Healey JS, Yee R, Tang A. Right ventricular apical pacing: a necessary evil? Curr Opin Cardiol 2007;22:33-8.
58. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.
59. Tops LF, Schalij MJ, Holman ER, van Erven L, van der Wall EE, Bax JJ. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642-8.
60. Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 2000;101:869-77.
61. Catanzariti D, Maines M, Cemin C, Broso G, Marotta T, Vergara G. Permanent direct His bundle pacing does not induce ventricular dyssynchrony unlike conventional right ventricular apical pacing. An intrapatient acute comparison study. J Interv Cardiac Electrophysiol 2006;16:81-92.
62. Occhetta E, Bortnik M, Magnani A, Francalacci G, Piccinino C, Plebani L et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 2006;47:1938-45.
63. Stambler BS, Ellenbogen K, Zhang X, Porter TR, Xie F, Malik R et al. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:1180-6.
64. Mera F, DeLurgio DB, Patterson RE, Merlino JD, Wade ME, Leon AR. A comparison of ventricular function during high right ventricular septal and apical pacing after His-bundle ablation for refractory atrial fibrillation. Pacing Clin Electrophysiol 1999;22:1234-9.
65. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-5.
66. Williamson BD, Man KC, Daoud E, Niebauer M, Strickberger SA, Morady F. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994;331:910-7.
67. Morady F, Hasse C, Strickberger SA, Man KC, Daoud E, Bogun F et al. Longterm follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 1997;29:113-21.
68. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43:2044-53.
69. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-28.
70. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
71. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5.
72. Hsieh MH, Tai CT, Lee SH, Tsao HM, Lin YK, Huang JL et al. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2005;16:457-61.
73. Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004;43:1201-8.
74. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.